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ABSTRACT Klebsiella pneumoniae is considered a significant public health threat be-
cause of the emergence of multidrug-resistant strains and the challenge associated
with treating life-threatening infections. Capsule, siderophores, and adhesins have
been implicated as virulence determinants of K. pneumoniae, yet we lack a clear un-
derstanding of how this pathogen causes disease. In a previous screen for virulence
genes, we identified a potential new virulence locus and constructed a mutant (smr)
with this locus deleted. In this study, we characterize the smr mutant and show that
this mutation renders K. pneumoniae avirulent in a pneumonia model of infection.
The smr mutant was expected to have a deletion of three genes, but subsequent
genome sequencing indicated that a much larger deletion had occurred. Further
analysis of the deleted region indicated that the virulence defect of the smr mutant
could be attributed to the loss of FepB, a periplasmic protein required for import of
the siderophore enterobactin. Interestingly, a ΔfepB mutant was more attenuated
than a mutant unable to synthesize enterobactin, suggesting that additional pro-
cesses are affected. As FepB is highly conserved among the members of the family
Enterobacteriaceae, therapeutic targeting of FepB may be useful for the treatment of
Klebsiella and other bacterial infections.
IMPORTANCE In addition to having a reputation as the causative agent of several
types of hospital-acquired infections, Klebsiella pneumoniae has gained widespread
attention as a pathogen with a propensity for acquiring antibiotic resistance. It is ca-
pable of causing a range of infections, including urinary tract infections, pneumonia,
and sepsis. Because of the rapid emergence of carbapenem resistance among Kleb-
siella strains, there is a dire need for a better understanding of virulence mecha-
nisms and identification of new drug targets. Here, we identify the periplasmic trans-
porter FepB as one such potential target.
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Klebsiella pneumoniae is a Gram-negative bacterium commonly classified as anopportunistic nosocomial pathogen capable of causing a variety of infections,
including urinary tract infections, pneumonia, and sepsis (1–5). It is often found as a
commensal resident of the gastrointestinal tract, and this is believed to be a primary
source of infection (2, 6–8). Recently, K. pneumoniae also has been shown to be capable
of causing community-acquired infections such as pyogenic liver abscesses, meningitis,
and endophthalmitis (9–11). The increasing prevalence of antibiotic-resistant strains
only serves to compound the clinical importance of K. pneumoniae and the difficulty of
treating those infected with extended-spectrum -lactamase-resistant or carbapenem-
resistant strains (12–16). Resistance to carbapenems is of particular concern, as they are
used as drugs of last resort to treat Gram-negative infections (12, 17).
During infection, sequestration of iron by the host limits the availability of free iron,
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and as a result, bacteria produce their own chelators to scavenge iron. Iron acquisition
is an essential component of most bacterial pathogens, as iron is required for cellular
and metabolic activities (18). Siderophores are small secreted molecules with a high
affinity for ferric iron; these are classified on the basis of the chemical nature of the Fe3
coordination (19). The catecholate-type siderophore enterobactin is produced by most
K. pneumoniae strains (20, 21). However, community-acquired isolates and those that
cause invasive disease typically encode additional siderophore systems (salmochelin,
yersiniabactin, aerobactin) (22). Salmochelin is a C-glucosylated enterobactin produced
by some isolates of Salmonella, Escherichia coli, and Klebsiella, and its synthesis is
dependent on enterobactin. Mutants unable to produce enterobactin are also unable
to produce salmochelin (23, 24). The iroA locus encodes enzymes necessary to modify
enterobactin, as well as proteins required for salmochelin transport (25). The yersini-
abactin locus is found in many invasive K. pneumoniae isolates and encodes a
phenolate-type siderophore that was first identified as part of a pathogenicity island in
Yersinia (26). Interestingly, in a genome-wide association study of a broad range of
K. pneumoniae isolates, yersiniabactin was found to be the most prevalent virulence-
associated locus and was found to be a predictor of infection versus carriage (22).
Aerobactin is yet another siderophore produced by a smaller fraction of K. pneumoniae
strains than either enterobactin or yersiniabactin (22). Although aerobactin has a lower
affinity for Fe3 than enterobactin or yersiniabactin, it is frequently produced by
isolates from pyogenic liver abscesses (27).
To date, the identified virulence factors of K. pneumoniae primarily include capsule,
lipopolysaccharide (LPS), fimbriae, and siderophores, and these factors also have
been identified as virulence factors in the strain used for the studies presented here
(4, 28–34). Several high-throughput studies have been done with mouse models to
identify additional bacterial virulence factors (34–40). Two of these screens were
signature-tagged mutagenesis (STM) screens for factors affecting gastrointestinal col-
onization and/or infection of the urinary tract (36, 37). These studies identified adhesins,
LPS, and capsule. Another screen for gain of function when Klebsiella genes were
expressed in E. coli identified a response regulator, AcrA, and LPS (40). A screen for
genes expressed in vivo during septicemia identified genes involved in the use of
siderophores (aerobactin and enterobactin) (39), and an STM screen in a model of liver
abscess formation identified adhesins and regulators (38). Two of these studies focused
on the identification of bacterial genes needed for survival in the lung; one approach
used STM, and the other used transposon insertion site sequencing (34, 35). These
screens identified capsule, LPS, siderophores, and transcriptional regulators. All of these
screens also identified genes predicted to contribute generally to growth, as well as
genes of unknown function.
Overall, there has been a lack of overlap in identified genes among the different
screens conducted with lung, urinary tract, liver infection, and gastrointestinal coloni-
zation models. This may be due to the fact that none of the screens were saturating, or
it could be indicative of mechanisms that compensate for the loss of individual genes.
These findings are further complicated by the use of different infection models and
different pathogen and host strain backgrounds. While typically focused on the goal of
identifying previously unknown bacterial factors contributing to disease, these screens
primarily identified known virulence factors of K. pneumoniae, as well as metabolic
functions generally contributing to growth.
We previously conducted an STM screen of K. pneumoniae in an intranasal model of
pneumonia to identify virulence genes (34). From this screen, yersiniabactin was
identified as important for the abilities of our strain to colonize the lungs and to cause
disseminated infection (33). In addition, a number of mutants with insertions in or near
ramA were identified (34). RamA has been implicated in virulence and multidrug
resistance in other pathogenic bacteria, and mutations in ramA have been associated
with fluoroquinolone resistance in K. pneumoniae (41–44). Furthermore, a recent study
reported that overexpression of RamA affects virulence and results in modified LPS (45).
Thus, we sought to determine if RamA is a virulence determinant for a highly virulent
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K. pneumoniae strain. These studies found no role for ramA or nearby genes for
virulence in a pneumonia model of infection. However, a serendipitous secondary
mutation was identified, and further analysis of this mutation indicates that FepB, a
periplasmic protein required for transport of enterobactin and salmochelin, is essential
for virulence. Surprisingly, there were interesting differences in virulence between
enterobactin synthesis mutants and the ΔfepB mutant.
RESULTS
The smr mutant is severely attenuated in a mouse model of pneumonia. A
previous screen of strain KPPR1 transposon mutants identified genes required for
colonization and survival in the lungs of infected mice (34). Thirteen mutants contain-
ing disruptions within ramA or an adjacent gene, orf82, failed to be recovered from the
lungs and spleens of infected mice. RamA is a transcriptional regulator linked to
Salmonella survival in RAW 264.7 macrophages and virulence in BALB/c ByJ mice (41,
42). This led us to hypothesize that the ramA locus is important for the ability of
K. pneumoniae to infect the lungs. To test this, we constructed the smr (spontaneous
multidrug resistance) mutant, where ramA and the two flanking genes (orf82 and romA)
were targeted for deletion, and tested this strain in a mouse model of pneumonia
(Fig. 1). The smr mutant caused slightly lower bacterial burdens at 24 h postinoculation
(hpi) than KPPR1 (wild type [WT]). At 72 hpi, nearly 5 logs fewer CFU were recovered
from mice infected with the smr mutant than from WT-infected mice. The spleens of
mice infected with the WT strain had nearly 107 CFU/g of tissue, while the smr mutant
was rarely detectable in the spleen at 72 hpi, reflecting a dissemination or systemic
survival defect. Together, these data indicate that the smrmutant is essentially avirulent
in this infection model.
Deletions of individual genes in the targeted smr locus do not recapitulate the
phenotype of the smr mutant. To identify the gene(s) responsible for the phenotype
of the smr mutant, we made in-frame deletions of each of the three genes (ΔramA,
ΔromA, and Δorf82) in the smr locus and tested them in our pneumonia model (Fig. 2A).
The phenotype of all three mutant strains resembled that of the WT, suggesting that
the loss of a single gene was not sufficient to affect virulence (Fig. 2B). We concluded
that neither ramA, orf82, nor romA, individually contributed to virulence in this model
or was responsible for the phenotype of the smr mutant.
In examining the region more closely, we noted that an RND (resistance-nodulation-
division superfamily) efflux pump system was encoded just upstream of orf82 and that
the smr deletion could have impacted the promoter driving the expression of this locus
(Fig. 2A). RND efflux systems have been shown to play roles ranging from resistance to
human antimicrobial peptides in Pseudomonas to flagellar motility in Burkholderia (46).
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FIG 1 The smrmutant is attenuated in a mouse model of pneumonia. Mice were inoculated i.n. with 2
104 CFU of either the WT strain (KPPR1S; black circles) or the Δsmr mutant (VK82; white squares). At 24
or 72 hpi, mice were euthanized and their lungs and spleens were homogenized and plated for bacterial
enumeration. Each symbol represents one mouse. The dotted line indicates the limit of detection, and
symbols on the dotted line indicate that CFU counts were below the limit of detection. Data are from an
individual representative experiment. Mann-Whitney tests were performed for statistical analysis. *, P 
0.05.
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Thus, we constructed two additional mutants, one with the rnd genes and the other
with orf82, ramA, and romA deleted but with the putative rnd promoter intact (Δrnd and
Δorf82 ramA romA). The Δrnd mutant colonized mice as efficiently as the WT strain
(Fig. 2B). Intriguingly, the second mutant lacking the same three genes as the smr
mutant (Δorf82 ramA romA) also had no virulence defect.
Sequencing of the smr mutant reveals a large deletion. As targeted genetic
mutations in the smr locus failed to recapitulate the smr phenotype, we hypothesized
that the smr mutant contained a secondary mutation. Whole-genome sequencing
revealed that the deletion in the smr mutant was larger than intended. Instead of the
targeted deletion of orf82, ramA, and romA, a single segment of 87,290 bp spanning 78
putative open reading frames was deleted.
A component of the enterobactin transport system contributes to virulence. To
identify the factor(s) responsible for the virulence defect of the smr mutant, we
constructed three mutants (Δsmr_A, Δsmr_B, and Δsmr_C) each with a deletion of
approximately one-third of the genes deleted in the smr mutant (Fig. 3A). The putative
orf genes in each mutant are listed in Table 1. In our pneumonia model at 24 and
72 hpi, both Δsmr_A and Δsmr_B mutant-infected mice had bacterial burdens compa-
rable to those of mice infected with the WT (Fig. 3B). However, the mice infected with
Δsmr_C mutant had 1 log fewer CFU/g at 24 hpi and nearly 6 logs fewer CFU/g at
72 hpi than mice infected with the WT. Thus, the Δsmr_C mutant recapitulated the
phenotype of the smr mutant, whereas the Δsmr_A and Δsmr_B mutants behaved like
the WT strain.
Located within the region deleted in the Δsmr_Cmutant are genes necessary for the
synthesis, export, and import of the siderophore enterobactin. We therefore hypothe-
sized that a component of the enterobactin transport system was responsible for the
virulence defect of the smr mutant. We did not believe that the siderophore itself was
responsible, as an ΔentB mutant, which is unable to synthesize enterobactin and
salmochelin, is only modestly attenuated in this mouse pneumonia model (33). The
enterobactin receptor FepA also was not implicated, as FepA is encoded within the
region deleted in the Δsmr_B mutant.
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FIG 2 Schematic of smr targeted region and in vivo phenotypes of mutants. (A) Schematic depicting
open reading frames within or adjacent to the smr target region (not to scale). Lines indicate the regions
deleted in the mutants indicated. (B) Mice were inoculated i.n. with 2 104 CFU of the WT strain (KPPR1S;
black circles) or the Δsmr (VK082; white squares), ΔramA (VK174; black diamonds), Δorf82 (VK270; white
circles), ΔromA (VK131; black squares), Δorf82 ramA romA (VK266; white diamonds), or Δrnd (VK269;
inverted triangles) mutant. At 24 or 72 hpi, mice were sacrificed and their lungs and spleens were
homogenized and plated for bacterial enumeration. Each symbol represents one mouse. The dotted line
indicates the limit of detection, and symbols on the dotted line indicate that CFU counts were below the
limit of detection. These data were compiled from several independent experiments. Mann-Whitney tests
were performed for statistical analysis. ***, P  0.001; ****, P  0.0001.
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Siderophore transport involves several membrane proteins. For enterobactin, EntS
and TolC are required for export, whereas FepA, FepDGC, and Fes are required for
import. In addition, the periplasmic protein FepB is required for the import of both
enterobactin and salmochelin. Because previous studies had implicated siderophore
transport components in virulence (47), we targeted specific components of the
enterobactin siderophore transport system and tested loss-of-function (ΔentS, Δfes,
ΔfepB, and fepD::pKAS46) mutants in our pneumonia model (Fig. 4A). We included a
different enterobactin synthesis (ΔybdB2 entABEC [referred to as Δentsyn]) mutant to
confirm our previous findings obtained with the ΔentBmutant (33). We found that only
the ΔfepB mutant recapitulated the phenotype of the smr mutant, as demonstrated by
the attenuation in the lungs and the lack of dissemination at 24 and 72 hpi (Fig. 4B).
Consistent with previously studies, neither the Δentsyn mutant (Fig. 4B) nor the ΔentB
mutant (Fig. 5) recapitulated the smr phenotype (33). In addition, loss of fepB did not
affect the expression of the yersiniabactin system (Fig. 6), consistent with results
previously obtained with an enterobactin synthesis mutant (33). Thus, the periplasmic
transport protein FepB contributes to virulence in a manner distinct from that of
enterobactin and salmochelin uptake alone.
A variety of different approaches were used to complement the ΔfepB mutant, but
all were unsuccessful. Plasmid-based approaches failed to complement growth under
iron-depleted conditions, despite the constitutive expression of fepB (data not shown).
We also attempted to repair the deletion, but this strain could not be obtained, for
reasons we do not understand. Problems with fepB complementation are not unprec-
edented and were also reported for a Salmonella fepB mutant (47). To ensure that the
observed phenotype of the ΔfepB mutant was not a consequence of secondary
mutations, a second fepBmutant (fepB2) was constructed and found to recapitulate the
virulence and growth phenotypes of the original fepB mutant (Fig. 5). Additionally, we
sequenced across the deletion junction of both of the ΔfepB mutants and obtained the
expected sequence, suggesting that a larger deletion of the region surrounding fepB
had not occurred (data not shown). Expression of the genes adjacent to fepB, entC and
entS, was assessed by quantitative reverse transcription-PCR. Expression of entC and
entS was not detected in the ΔfepB mutant but was in the WT (data not shown). EntC
and EntS may be needed for growth under low-iron conditions, and their lack of
expression provides a possible explanation for failed complementation in trans. How-
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FIG 3 The smr mutant phenotype is recapitulated by a smaller targeted deletion. (A) Schematic
depicting targeted subregions of the smrmutant (not to scale). (B) Mice were inoculated i.n. with 2 104
CFU of the WT (KPPR1S; black circles) or the Δsmr (VK082; open squares), Δsmr_A (VK274; black triangles),
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sacrificed and their lungs and spleens were homogenized and plated for bacterial enumeration. Each
symbol represents one mouse. The dotted line indicates the limit of detection, and symbols on the
dotted line indicate that CFU counts were below the limit of detection. X indicates a mouse that
succumbed to infection prior to 72 hpi. These data are from an individual representative experiment.
Mann-Whitney tests were performed for statistical analysis. *, P  0.05.
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TABLE 1 Genes deleted in breakdown mutants
Strain Locus tag Annotated gene product
Δsmr_A mutant VK055_1987 Oxygen-insensitive NADPH nitroreductase
VK055_1986 Hypothetical protein
VK055_1985 Bacterial transcriptional regulator, TetR family
VK055_1984 Metallo-beta-lactamase superfamily protein (RomA)
VK055_1983 Bacterial regulatory helix-turn-helix, AraC family protein (RamA)
VK055_1982 Hypothetical protein (Orf82)
VK055_1981 Putative aldo/keto reductase
VK055_1980 HADa ATPase, P type
VK055_1979 Efflux transporter, RND family, MFP subunit
VK055_1978 Efflux pump membrane transporter, BepE
VK055_1977 Hypothetical protein
VK055_1976 Gamma-glutamyl cysteine ligase YbdK
VK055_1975 Hypothetical protein
VK055_1974 Bacterial extracellular solute-binding protein
VK055_1973 Binding-protein-dependent transport system inner membrane component
VK055_1972 Binding-protein-dependent transport system inner membrane component
VK055_1971 Oligopeptide/dipeptide ABC transporter, ATP binding
VK055_1970 Oligopeptide/dipeptide ABC transporter, ATP binding
VK055_1969 Amidase. Hydatoinase/carbamoylase family protein
VK055_1968 EamA-like transporter family protein
VK055_1967 Bacterial transcriptional regulator, GntR family protein
VK055_1966 Bacterial transcriptional regulator, GntR family protein
VK055_1965 Bacterial extracellular solute-binding
VK055_1964 ABC transporter, permease
VK055_1963 ABC-type amino acid transport system, permease
VK055_1962 ABC transporter family protein
VK055_1961 Serine 3-dehydrogenase
VK055_1960 Aminotransferase class III family protein
Δsmr_B mutant VK055_1959 ABC transporter family protein
VK055_1958 ABC transporter family protein
VK055_1957 Oligopeptide transport permease family protein
VK055_1956 Binding protein-dependent transport system inner membrane component family protein
VK055_1955 Bacterial extracellular solute-binding protein
VK055_1954 Acetyltransferase family protein
VK055_1953 Choline dehydrogenase
VK055_1952 Betaine aldehyde dehydrogenase
VK055_1951 Transcriptional repressor BetI
VK055_1950 Transporter, betaine/carnitine/choline transporter family protein
VK055_1949 ykfE, inhibitor of vertebrate C-type lysozyme
VK055_1948 Bacterial regulatory helix-turn-helix, LysR family protein
VK055_1947 Mechanosensitive ion channel family protein
VK055_1946 Hypothetical kinase
VK055_1945 Glycerol kinase
VK055_1944 L-Fucose isomerase, C-terminal domain protein
VK055_1943 Transketolase, pyrimidine binding domain protein
VK055_1942 Thiamine pyrophosphate enzyme, C-terminal TPPb binding domain protein
VK055_1941 Hypothetical protein
VK055_1940 Putative transcriptional regulator
VK055_1939 Branched-chain amino acid transport system/permease component family protein
VK055_1938 Heme ABC exporter, ATP-binding protein CcmA
VK055_1937 Hypothetical protein
VK055_1936 Periplasmic binding and sugar binding domain of LacI family protein
VK055_1935 4=-Phosphopantetheinyl transferase superfamily protein, EntD
VK055_1934 TonB-dependent siderophore receptor family protein, FepA
Δsmr_C mutant VK055_1933 Fes
VK055_1932 MbtH-like family protein
VK055_1931 EntF
VK055_1930 FepC
VK055_1929 FepG
VK055_1928 FepD
VK055_1927 EntS
VK055_1926 FepB
VK055_1925 EntC
VK055_1924 EntE
(Continued on next page)
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ever, this alone cannot explain the attenuation in vivo, as a ΔentS mutant was not
attenuated and a ΔentC mutant (enterobactin synthesis) had a more modest attenua-
tion level than the ΔfepB mutant (Fig. 4A) (33). Thus, we conclude that deletion of fepB
results in a phenotype distinct from that of other enterobactin system mutants.
A fepB mutant resembles a entB ybtS double mutant. We previously showed
that a ΔentB ybtS mutant that is deficient in all siderophore production was severely
attenuated (33). In comparing the defect of the ΔfepB mutant strain to those of other
siderophore mutants, we noticed that the phenotype of the ΔfepB mutant was similar
to that of the ΔentB ybtS mutant. Because the attenuation of the ΔfepB mutant was
much greater than that of the ΔentB mutant, we hypothesized that the role of FepB is
not limited to enterobactin import and that it might be involved in an additional iron
acquisition system. To gain a better understanding of the relationship between the
phenotypes of these mutants, we tested the ΔfepB mutant together with the ΔentB
ybtS mutant to determine if its virulence defect resembles that of a ΔentB ybtS
mutant in vivo and included a ΔentB mutant as a control (Fig. 5). The ΔfepB and ΔentB
ybtS mutants had similar attenuation levels, which were more severe than that of the
TABLE 1 (Continued)
Strain Locus tag Annotated gene product
VK055_1923 EntB
VK055_1922 EntA
VK055_1921 Proofreading thioesterase in enterobactin biosynthesis, YbdB2
VK055_1920 Carbon starvation CstA family protein
VK055_1919 Helix-turn-helix family protein
VK055_1918 Hypothetical protein
VK055_1917 Plasmid stabilization system family protein
VK055_1916 Short-chain dehydrogenase family protein
VK055_1915 Iron-containing alcohol dehydrogenase family protein
VK055_1914 ABC transporter family protein
VK055_1913 Branched-chain amino acid transport system/permease component family protein
VK055_1912 Periplasmic binding and sugar binding domain of LacI family protein
VK055_1911 LVIVD repeat family protein
aHAD, haloacid dehalogenase.
bTPP, thiamine pyrophosphate.
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FIG 4 FepB is responsible for the smr mutant’s phenotype. (A) Schematic of the enterobactin genes
located in the Δsmr_C region. (B) Mice were inoculated i.n. with 2  104 CFU of the WT (KPPR1S; black
circles) or the Δsmr (VK082; open squares), ΔfepB (VK412; black diamonds), Δent syn (VK321; open circles),
ΔentS (VK411; black squares), Δfes (VK320; black inverted triangles), or fepD::kan (VK413; open triangles)
mutant. At 24 or 72 hpi, mice were sacrificed and their lungs and spleens were homogenized and plated
for bacterial enumeration. Each symbol represents one mouse. The dotted line indicates the limit of
detection, and symbols on the dotted line indicate that CFU counts were below the limit of detection.
The data are from an individual representative experiment. Mann-Whitney tests were performed for
statistical analysis. *, P  0.05. **, P  0.01.
FepB and Klebsiella Virulence
July/August 2017 Volume 2 Issue 4 e00341-17 msphere.asm.org 7
ΔentB mutant. This finding raises the question of whether FepB may be required for
iron acquisition via systems other than enterobactin and salmochelin.
To address the role of FepB in iron uptake and to determine if the virulence defect
could be due to reduced iron acquisition, we used an in vitro growth model. The ΔfepB,
ΔentB, and ΔentB ybtS mutants were grown in defined medium with or without the
iron-chelating agent 2,2=-dipyridyl (DP). All of the strains had similar growth rates
in the absence of DP, indicating that the mutants grow normally when iron levels
are sufficient (Fig. 7A). However, in the presence of DP, the growth of the ΔfepB and
ΔentB ybtS mutants was severely restricted (Fig. 7B). Interestingly, the growth of the
ΔentB mutant was restricted compared to that of the WT strain, but the triple sidero-
phore (ΔentB ybtS) mutant and the ΔfepB mutant grew even more slowly than the
ΔentB mutant. These data suggest that FepB contributes to growth in an iron-
dependent manner that is distinct from its known role in enterobactin and salmochelin
uptake.
Yersiniabactin import is unaffected in a fepB mutant. The ΔfepB mutant had a
stronger phenotype than an enterobactin/salmochelin synthesis mutant, and it resem-
bled that of a triple siderophore mutant in both virulence and growth under iron
limitation. Yersiniabactin is the only known siderophore produced by the ΔentBmutant
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FIG 5 A ΔfepB mutant resembles a triple siderophore mutant in vivo. Mice were inoculated i.n. with 2 
104 CFU of the WT (KPPR1S; black circles) or the ΔfepB (VK412; open squares, small closed circles), ΔentB
mutant (VK087; open diamonds), or ΔentBybtS (VK089; black squares) mutant. At 24 or 72 hpi, mice were
sacrificed and their lungs and spleens were homogenized and plated for bacterial enumeration. Each
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representative experiment. Mann-Whitney tests were performed for statistical analysis. *, P  0.05.
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FIG 6 ybtA expression is unchanged in the ΔfepB mutant. The WT strain and a ΔfepB mutant containing
the yersiniabactin synthesis gene, ybtA, promoter cloned into the pPROBE gfp reporter plasmid were
grown overnight, subcultured to an OD600 of 0.2, and grown in LB medium for 6 h with or without
200 M DP. These data are from strains grown in triplicate in an individual experiment. Student t tests
were performed for statistical analysis. ***, P 0.0001; ns, not significant. RFU, relative fluorescence units.
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but not the ΔentB ybtS mutant. Thus, we wanted to assess if the ΔfepB mutant is
defective in yersiniabactin uptake. To do this, we performed a cross-feeding experiment
to determine if the growth defect of the ΔfepB mutant under iron-limited conditions
could be restored in the presence of yersiniabactin by coculturing the ΔfepB mutant
with a yersiniabactin-producing strain. We predicted that if FepB is required for
yersiniabactin import, a feeder strain producing yersiniabactin would be unable to
restore the growth of the ΔfepB mutant. In this assay, test strains were spread onto M9
medium supplemented with 0.4% glucose and 0.2% Casamino acids (M9-CAA) agar
containing DP and feeder strains were then spotted onto the surface of the plates. The
WT and ΔentB, ΔentB ybtS, and ΔfepBmutant strains were used as test strains, and the
WT and the ΔentB (capable of producing yersiniabactin) and ΔybtS (does not produce
yersiniabactin) mutants were used as feeder strains. As expected, the ΔybtSmutant was
not able to complement the growth defect of the ΔfepB mutant, as the ΔfepB mutant
should not be able to use the enterobactin produced by this strain (Fig. 8A). The WT
and the ΔybtSmutant were able to complement the growth of the ΔentB ybtSmutant,
as expected (Fig. 8B). Importantly, the ΔentB mutant and the WT were able to restore
the growth of the ΔentBmutant (as expected), as well as the ΔfepBmutant. This finding
suggests that yersiniabactin can still be imported by a ΔfepB mutant.
To determine if the complementation of the ΔfepB mutant’s growth defect by a
yersiniabactin-producing strain in the cross-feeding experiment was due to yersiniabac-
tin production rather than the production of other secreted bacterial products, we
performed a similar experiment by spotting purified apo-yersiniabactin instead of
feeder strains. As described above, test strains (WT strain and ΔfepB and ΔentB ybtS
mutants) were spread onto M9-CAA agar containing DP. Various concentrations of
apo-yersiniabactin were applied to paper discs that were placed on the agar plate to
test for growth restoration and thus the ability to utilize yersiniabactin (Fig. 8C). The WT
strain was able to grow even without yersiniabactin supplementation. The ΔentB ybtS
and ΔfepB mutants did not grow around the vehicle control (distilled H2O [dH2O]) disc.
However, upon the addition of yersiniabactin, the growth defect of the ΔentB ybtS
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FIG 7 The ΔfepBmutant has a growth defect under iron-limited conditions. The WT strain (KPPR1S; black
circles) and the ΔfepB (VK412; open squares), ΔentB (VK087; open circles), and ΔentBybtS (VK089; black
diamonds) mutants were grown in M9-CAA (A) or in M9-CAA supplemented with 100 M DP (B). The
OD600 was monitored for 6 h. The data shown are from an individual representative experiment.
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mutant was restored in a concentration-dependent manner; this is an expected result
because this strain is still able to import exogenous yersiniabactin. Addition of apo-
yersiniabactin also restored the growth of the ΔfepB mutant (Fig. 8C). Together, these
data suggest that FepB is not required for yersiniabactin import in vitro and that the
virulence defect of the ΔfepBmutant is due to a mechanism unrelated to yersiniabactin
import.
Capsule production is not responsible for the fepB mutant’s phenotype.
Capsule is considered a primary virulence factor of K. pneumoniae (reviewed in refer-
ence 4). Therefore, to test if there was a change in capsule production that could
contribute to the ΔfepB mutant’s phenotype, we measured its uronic acid content.
When the ΔfepB mutant and the WT strain were grown in Luria-Bertani (LB) medium at
37°C, the same conditions used for the inoculum used in mouse experiments, there was
no difference in capsule production (Fig. 9A). Similarly, when mucoviscosity was
measured (another assay for capsule phenotypes), we saw no measureable difference
between the WT and the ΔfepB mutant (Fig. 9B).
Because iron levels can affect K. pneumoniae capsule production (48), we decided to
test if capsule production is altered in the ΔfepB mutant under low-iron conditions. All
four siderophore system (ΔfepB, ΔentB, ΔybtS, and ΔentB ybtS) mutants had a modest,
nonsignificant reduction in capsule production (Fig. 9C). The mucoviscosity of the
siderophore system mutants was also lower than that of the WT (Fig. 9D). Importantly,
there was no difference between the capsule production levels of the ΔfepB and ΔentB
mutants. How FepB affects virulence is not clear, but it does not appear to be related
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FIG 8 Addition of yersiniabactin restores the growth defect of the ΔfepB mutant under iron-limited
conditions. Test strains were grown in M9-CAA and spread plated onto M9-CAA agar containing 100 M
DP. (A) Plate testing of the ΔfepB mutant (spread plated). Feeder (WT and ΔentB and ΔybtS mutant)
strains were then spot plated to test for complementation (growth restoration around the feeder spot).
(B) Summary of results represented as  for growth and – for no growth of the WT strain, the ΔfepB
mutant, the ΔentB mutant, or the ΔentB ybtS double mutant. (C) Addition of purified yersiniabactin
(1 mM or 100 M) or the dH2O vehicle to the WT strain, the ΔfepB mutant, or the ΔentB ybtS double
mutant. Shown are data from an individual experiment that are representative of data obtained from
several independent experiments.
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to the amount of capsule produced (Fig. 9A and C)) or the mucoviscosity of the capsule
(Fig. 9B and D), as the uronic acid content and sedimentation of the ΔfepBmutant were
comparable to those of the enterobactin synthesis mutant, which is only modestly
attenuated.
DISCUSSION
The repertoire of confirmed K. pneumoniae virulence factors has changed little
during the past 2 decades (2, 4). Although a number of large screens for K. pneumoniae
virulence determinants have been performed (34–40), unfortunately, there have been
few follow-up analyses of the results of these screens. In a screen of signature-tagged
mutants in a pneumonia model of infection, we identified a locus that included ramA
as potentially important for virulence (34), and a recent study suggested that overex-
pression of ramA affects virulence and leads to LPS modifications (45). In this study, we
constructed a mutant (smr) with this locus deleted and found that it was cleared from
the lungs following intranasal inoculation and that it was unable to spread systemically.
Why deletion of ramA or the surrounding genes did not result in a virulence defect in
the lungs and/or spleen when 11 insertions in this region were identified in the STM
screen remains a mystery (34). One possibility is that in the STM screen, each insertion
mutant was screened essentially in competition with 95 other mutants, most of which
behave like the WT strain. Therefore, a ramA mutant may have a competitive disad-
vantage when at a ratio of ~1:100 with the WT but will not exhibit a defect when
inoculated on its own. RamA has been implicated in the regulation of pathways
important for multidrug resistance (43, 44), and thus, it may still be important in the
context of antibiotic treatment or in a strain background that is not hypervirulent.
Subsequent analysis of the smr mutant indicated that the virulence defect was due
not to deletion of the ramA locus but rather to the deletion of fepB, a gene encoding
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FIG 9 Capsule phenotype of the ΔfepB mutant. Overnight cultures of the WT strain, the ΔfepB mutant,
and a capsule-deficient strain (cpsB::Tn5Kn2) were subcultured to an OD600 of 0.2 and grown in LB
medium for 6 h, and total capsule production was measured with the uronic acid assay (A) and the
low-speed centrifugation assay to measure mucoviscosity (B). These data are from strains grown in
triplicate in an individual experiment. One-way analysis of variance, followed by Dunnett’s multiple-
comparison test, was performed for statistical analysis. ***, P 0.001; ****, P 0.0001; ns, not significant.
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a protein required for enterobactin and salmochelin import (49–51). The fepB mutant
had a more severe growth defect in iron-limited medium and a more severe in vivo
defect than an enterobactin synthesis (ΔentB) mutant; the ΔentB mutant would also be
deficient in salmochelin production. The contributions of the siderophores enterobac-
tin, salmochelin, and yersiniabactin to Klebsiella virulence have been examined previ-
ously, and individually, they were found to contribute only minimally to infection (32,
33, 52). The data presented here reveal that while enterobactin/salmochelin may be
dispensable for the virulence of a strain also able to produce yersiniabactin in a
K. pneumoniae lung infection model, the enterobactin/salmochelin importer FepB is
necessary to establish infection. Furthermore, under both in vitro and in vivo conditions,
the ΔfepB mutant resembles a ΔentB ybtS mutant, which is unable to produce any of
the three siderophores encoded by this strain (enterobactin, salmochelin, and yersini-
abactin). Together, these observations suggest that FepB contributes to virulence and
growth under iron limitation in an unanticipated way.
Siderophores are synthesized in the cytoplasm and require machinery for export
and subsequent import following iron sequestration. Enterobactin is synthesized by
EntABCDEF and is exported to the periplasm via the inner membrane protein EntS and
subsequently through the outer membrane via the membrane channel protein TolC
(53). Once bound to ferric iron, enterobactin (enterobactin-Fe3) binds the outer
membrane siderophore receptor FepA and is translocated into the periplasm by a
TonB-dependent mechanism. In the periplasm, enterobactin-Fe3 then binds the
periplasmic chaperone FepB and is shuttled to the inner membrane, where it interacts
with the inner membrane transport complex FepDGC and is ultimately released into
the cytoplasm (50, 54, 55). Salmochelin utilizes a similar export apparatus but is
imported via the bacterial outer membrane receptor IroN, and then FepB shuttles it to
FepDGC (56). Export and yersiniabactin import appear to be similar, although several
steps in yersiniabactin transport remain to be elucidated (53). Specifically, no periplas-
mic protein (FepB equivalent) has been identified in the yersiniabactin import system.
Because of the similarities in the phenotypes of the ΔfepB and triple siderophore
mutants and because no FepB equivalent has been identified in the yersiniabactin
import system, we initially hypothesized that FepB may be involved in yersiniabactin
import. However, our results show that a ΔfepBmutant can still utilize yersiniabactin for
growth in vitro, and thus, the role of FepB in growth under iron limitation and virulence
remains unclear. A recent crystal structure of FepB indicates that it can form a trimer
(57) and thus possibly could coordinate a target other than enterobactin-Fe3, but this
has yet to be demonstrated.
A contribution of the periplasmic enterobactin transporter FepB to pathogenesis
also was observed in Salmonella enterica (47). Salmonella produces both enterobactin
and salmochelin, and both siderophores require FepB for import (25). However, Nagy
et al. found that a fepB mutant had lower colonization levels in mice than a fepA-iroN
double mutant (encoding the outer membrane receptors for enterobactin and salmo-
chelin) in a gastric model of infection (47, 58). This is comparable to our results obtained
with K. pneumoniae and suggests that the role of FepB in virulence extends beyond
siderophore transport. The fact that this phenomenon has been reported in two
Gram-negative pathogens hints that this may be a conserved mechanism in other
bacterial species. One possible explanation for this observation is that in a ΔfepB
mutant, enterobactin is not recycled properly and accumulates extracellularly and
perhaps this is detrimental to the bacteria, given that enterobactin can enhance copper
toxicity (59). However, in this scenario, the Δsmr_C mutant (which is a ΔentB ΔfepB
double mutant and has other genes [listed in Table 1] deleted) should not have this
phenotype, as it would be unable to produce enterobactin. However, the data pre-
sented here suggest that this is not the case, as the Δsmr_C mutant has a virulence
defect comparable to that of a ΔfepB mutant.
Interestingly, recent studies have noted that the complement of siderophore sys-
tems produced by an individual strain of K. pneumoniae has a significant impact on its
ability to colonize versus its ability to cause an infection or its ability to cause invasive
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disease associated with the hypervirulence phenotype (22). In an analysis of a broad
sampling of over 300 strains, only 33% of an individual strain’s genome is part of the
core Klebsiella genome, and the remaining 67% is composed of “accessory” genes that
vary significantly from strain to strain (22). Until recently, the gene profiles necessary to
cause the different types of infections associated with K. pneumoniae were not clear.
However, recent bioinformatics analyses of large strain collections, combined with
information on the type of infection, have revealed that some specific gene profiles are
associated with colonization versus infection versus invasive disease. For example,
the presence of rmpA (a regulator of capsule), as well as the genes required for the
production and use of the siderophores aerobactin, salmochelin, and yersiniabactin,
was highly associated with strains isolated from infections versus carriage alone (22).
Interestingly, an additional five loci were associated with invasive infections (versus
noninvasive infections or carriage), including fepB. This is consistent with the require-
ment we observed for fepB to cause disseminated infection in mice and what has been
observed in Salmonella (47).
With antibiotic resistance on the rise, the development of new therapeutics to
combat infection by multidrug-resistant bacteria is an urgent need (60). Siderophore
systems present an attractive target for drug development because of the conservation
of these systems among Gram-negative pathogens (61). Immunization with the yers-
iniabactin receptor FyuA or the siderophores themselves (yersiniabactin and aerobac-
tin) was protective when tested in a murine model of E. coli urinary tract infection
(62–64). FepB may be an especially attractive target to consider for drug development,
as it is required for disseminated infections and is found in a wide variety of bacteria.
In addition to being potential targets for drug development, siderophores represent an
attractive system to exploit as a drug delivery mechanism to overcome the permeability
barrier of the outer membrane. In essence, the siderophore can be used as a “Trojan
horse” to target a siderophore-drug conjugate to the siderophore-iron transport sys-
tems (61). This would allow the delivery of drugs to the periplasm and potentially to the
cytoplasm. From the work presented here and with Salmonella, one such periplasmic
target could be FepB itself. Drug-siderophore conjugates have been developed, and a
catechol-cephalosporin conjugate, cefiderocol (S-649266), was found to have lower
MIC90s than the antibiotics cefepime, piperacillin-tazobactam, and meropenem when
tested against several Gram-negative bacteria, including multidrug- and carbapenem-
resistant strains (65–67). Cefiderocol displayed antibacterial properties when tested in
vivo and is currently being tested in a phase 3 clinical trial against carbapenem-resistant
Gram-negative infections in humans (66, 68). Thus, investigations probing the mecha-
nisms of siderophore transport can provide the basis for promising new therapeutics.
MATERIALS AND METHODS
Ethics statement.Mouse experiments were conducted in accordance with the Guide for the Care and
Use of Laboratory Animals of the National Institutes of Health (69). All animal studies were approved by
the Institutional Animal Care and Use Committee at the University of North Carolina (UNC) at Chapel Hill
(protocols 11-127 and 14-110). All efforts were made to minimize suffering. Animals were monitored daily
following inoculation and were euthanized upon exhibiting signs of morbidity.
Bacterial strains and culture conditions. The bacterial strains and plasmids used in this study are
described in Table 2. The WT parental strains are KPPR1, a Rifr derivative of ATCC 43816 (34), and KPPR1S,
a Strr derivative of KPPR1; they have identical growth characteristics in vitro and in vivo. K. pneumoniae
strains were grown aerobically in LB medium or M9-CAA overnight at 37°C. Where indicated, 100 or
200 M DP (Sigma-Aldrich, St. Louis, MO) was added to M9 or LB medium, respectively, to deplete the
available iron. Antibiotics were added to the medium as appropriate at the following concentrations:
kanamycin, 50 g/ml (Kan50); rifampin, 30 g/ml (Rif30); streptomycin, 500 g/ml (Strep500). Bacterial
growth was monitored by measuring the optical density at 600 nm (OD600).
Construction of bacterial mutants.Mutations in KPPR1S (ΔramA Δorf82, Δorf82ΔramAΔromA, ΔentS,
ΔybdB2 entABEC [referred to as Δentsyn], Δfes, ΔfepB, Δsmr_A Δsmr_B, and Δsmr_C) were generated by
allelic exchange by using pKAS46, a suicide vector that allows the use of streptomycin for counterse-
lection (70, 71). Sequences up- and downstream (~500 bp each) were generated by PCR with the primer
sets indicated in Table 3, cloned into pKAS46, and confirmed by sequence analysis. Overnight cultures
of KPPR1S and E. coli S17-1 pir (72) carrying a derivative of pKAS46 were mixed, collected by
centrifugation, plated on LB agar (no antibiotics), and grown overnight at 37°C. Transconjugants were
selected by plating on LB agar with Rif30 and Kan50. Several Rifr Kanr colonies were grown for 5 to 6 h
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in LB medium (no antibiotics) and then plated on LB agar with Strep500 to select for transconjugants that
had excised the plasmid. Kans clones were screened by PCR to verify the loss of the targeted gene(s).
An insertional disruption of the fepDCG operon was constructed in KPPR1S (fepD::pKAS46) by plasmid
integration into the fepD gene. A DNA fragment generated by PCR with primers MP313 and MP314
(Table 3) was cloned into pKAS46. The resulting plasmid, pKAS46fepD::kan, was conjugated into KPPR1S
as described above. Colonies with integration of the plasmid on the chromosome were identified by
plating on LB agar with Rif30 and Kan50.
Isogenic mutants of KPPR1 (ΔromA and Δsmr) were generated by allelic exchange with pKO3 as
previously described (73). pKO3 is a vector that allows the use of sucrose as a positive selection for the
loss of the vector. DNA fragments were amplified by PCR with the primer sets indicated in Table 3 and
cloned into pKO3, generating plasmids pKO3ΔromA and pKO3Δsmr.
Whole-genome sequencing of the smrmutant. Total DNA from the smrmutant (VK82) was isolated
with a genomic DNA purification kit (Qiagen), and the sample was submitted to the UNC High-
Throughput Sequencing Facility for sequencing. An Illumina HiSeq 2000 instrument generated 2 75-bp
paired-end reads. A mapped genome assembly was produced with the “Map Reads to Reference” tool
in CLC Genomics Workbench v7.5.1 by using the published KPPR1 genome as the template (74). The smr
mutant and KPPR1 parent strain genomes were then compared with the “Basic Variant Detection” tool
in CLC Genomics Workbench to identify mutations in the smr strain. Mutations were visualized by
aligning these genomes with Mauve (75).
TABLE 2 Bacterial strains and plasmids used in this work
Strain or plasmid Description Reference
E. coli
DH5 F 80dlacZΔM15 Δ(lacZYA-argF)U169 deoP recA1 endA1 hsdR17(rK mK) Invitrogen
S17-1 pir Tpr Strr recA thi pro hsdR hsdM RP4-2-Tc::Mu Km Tn7 pir (lysogen) 72
K. pneumoniae
KPPR1 Rifr derivative of ATCC 43816 34
KPPR1S Strr derivative of KPPR1 This work
VK060 KPPR1 cpsB::Tn5Kn2 34
VK082 smr mutant This work
VK087 KPPR1 ΔentB 33
VK088 KPPR1 ΔybtS 33
VK089 KPPR1 ΔentB ybtS 33
VK131 KPPR1 ΔromA This work
VK174 KPPR1S ΔramA This work
VK266 KPPR1S Δorf82 ΔramA ΔromA This work
VK269 KPPR1S Δrnd This work
VK270 KPPR1S Δorf82 This work
VK274 KPPR1S Δsmr_A This work
VK275 KPPR1S Δsmr_B This work
VK276 KPPR1S Δsmr_C This work
VK320 KPPR1S Δfes This work
VK321 KPPR1S ΔybdB2 entABEC (Δentsyn) This work
VK411 KPPR1S ΔentS This work
VK412 KPPR1S ΔfepB This work
VK413 KPPR1S fepD::pKAS46 This work
VK555 KPPR1S ΔfepB2 This work
Plasmids
pKAS46 vector Kanamycin resistance, suicide vector, rpsL 70
pK03 vector sacB, temperature-sensitive origin of replication 73
pPROBE vector Kmr, gfp expression vector 77
pKO3ΔromA romA flanking region in pKO3 This work
pKO3ΔramKO smr flanking region in pKO3 This work
pKAS46ΔramA ramA flanking region in pKAS46 This work
pKAS46Δorf82 orf82 flanking region in pKAS46 This work
pKAS46Δorf82ramAromA orf82 ramA romA flanking region in pKAS46 This work
pKAS46Δrnd rnd flanking region in pKAS46 This work
pKAS46ΔfepB fepB flanking region in pKAS46 This work
pKAS46Δsmr_A smr_A flanking region in pKAS46 This work
pKAS46Δsmr_B smr_B flanking region in pKAS46 This work
pKAS46Δsmr_C smr_C flanking region in pKAS46 This work
pKAS46Δfes fes flanking region in pKAS46 This work
pKAS46ΔentS entS flanking region in pKAS46 This work
pKAS46ΔybdB2entABEC ybdB2 entABEC (Δentsyn) flanking region in pKAS46 This work
pfepD::pKAS46 Disruption of fepD This work
pY4 ybtA promoter in pPROBE 33
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Murine model of pneumonia. Five- to 8-week-old, female C57BL/6 mice (Jackson Laboratories) were
anesthetized by intraperitoneal injection with 200 l of a mixture of ketamine (6.66 mg/kg) and xylazine
(10.6 mg/kg). Overnight bacterial cultures were diluted in phosphate-buffered saline (PBS), and 20 l was
inoculated intranasally (i.n.) in two 10-l aliquots for a total of ~2  104 CFU/mouse as previously
described (34). At 24, 48, or 72 hpi, mice were euthanized by a lethal injection of 200 l of sodium
pentobarbital (150 mg/kg). Organs were removed, homogenized in PBS, serially diluted, and plated to
quantify the number of CFU/g of tissue.
Mucoviscosity assay. Mucoviscosity was determined as previously described (35, 76). Briefly, over-
night cultures were grown in LB medium, subcultured to an OD600 of 0.2 in fresh medium, and grown
at 37°C. After 6 h, cultures were normalized to 1.0 U of OD/ml and centrifuged for 5 min at 1,000  g
and the OD600 of the supernatant was measured.
TABLE 3 Primers used in this study
Primer Sequencea (5= to 3=) Description
MP66 TGACTAGATATCGCTGATTACCGAAGCGGACTG 5= flank forward ΔramA
MP67 TGCATATCTAGAGGAAATCGTCATATGCTCTCT 5= flank reverse ΔramA
MP68 TGCATATCTAGACACTGAGGCGCGCCTCTCCTG 3= flank forward ΔramA
MP69 TCGATAGCGGCCGCCGACTGGCGCTGTACATCGCG 3= flank reverse ΔramA
MP114 TGACTAGATATCTCGCCCGAGGGCGTCGTAAAC 5= flank forward Δorf82
MP71 TGCATATCTAGACTCGAGCGGTAAACCAGGAGA 5= flank reverse Δorf82
MP72 TGCATATCTAGACAGTGGATGTTTCATGTCATG 3= flank forward Δorf82
MP115 TCGATAGCGGCCGCGGGATGAACCGTATCAACGGC 3= flank reverse Δorf82
MP124 TGACTAGATATCCGATTTTGCCTGCTATGCGCA 5= flank forward Δrnd
MP125 TGCATATCTAGACATCGGCGGGGGTAAGCGCGG 5= flank reverse Δrnd
MP126 TGCATATCTAGAGTTCACCCGGTCGCCCAGCGG 3= flank forward Δrnd
MP127 TCGATAGCGGCCGCGCCACGGCAGGTCTGGCAGCA 3= flank reverse Δrnd
MP103 TGACTAGATATCGGCGTCGTAAACTTTGGGTTA 5= for Δorf82 ramA romA
MP104 TGCATATCTAGATTCCAGTGGATGTTTCATGTC 5= rev Δorf82 ramA romA
MP105 TGCATATCTAGACTGACCAGACAAAAGCCCCCA 3= for Δorf82 ramA romA
MP106 TCGATAGCGGCCGCCGACAGCTGGCACATTTCGTT 3= rev Δorf82 ramA romA
MP171 TCGATAGCGGCCGCCTGTGCGCTCCCTGCGCCATG 5= flank forward smrΔA
MP172 TGCATATCTAGACTGGCGAAGTAGGGGAGGGGG 5= flank reverse smrΔA
MP173 TGCATATCTAGAACCGAGATTTAATCTCTCCAC 3= flank forward smrΔA
MP174 TGACTAGATATCTCCAACTTTTGGGGTGCAGTC 3= flank reverse smrΔA
MP175 TGACTAGATATCCCATGCGCTTGCGCGGGCCTA 5= flank forward smrΔB
MP176 TGCATATCTAGAGCTTACGATATTTCCAATCCG 5= flank reverse smrΔB
MP177 TGCATATCTAGATGCGCCTCATTAAGCGGGTCC 3= flank forward smrΔB
MP178 TCGATAGCGGCCGCAATGACAGAATGTTAAGGACA 3= flank reverse smrΔB
MP179 TGACTAGATATCTGCGCCTCATTAAGCGGGTCC 5= flank forward smrΔC
MP180 TGCATATCTAGAAGTCACGCTATACATAGGGTT 5= flank reverse smrΔC
MP181 TGCATATCTAGAGCGCACCCTGGCGGAGCCACT 3= flank forward smrΔC
MP182 TCGATAGCGGCCGCATTAACGACAGGTTGCGCGAA 3= flank reverse smrΔC
MP282 TGACTAGATATCAGAATTTAACAACACCGAAAC 5= flank forward ΔybdB2 entABEC
MP192 TGCATATCTAGAACCGCGGTGCTGGGCTAAGAA 5= flank reverse ΔybdB2 entABEC
MP193 TGCATATCTAGAAGCCAGTGACGTTTCCATATC 3= flank forward ΔybdB2 entABEC
MP194 TCGATAGCGGCCGCGCAACCTCGCTCCACTGGCGC 3= flank reverse ΔybdB2 entABEC
MP195 TGACTAGATATCGGATATAGAGCTCGGAAGGCT 5= flank forward ΔfepB
MP196 TGCATATCTAGAGAAGTTCACGTCATCGCATCC 5= flank reverse ΔfepB
MP197 TGCATATCTAGACTGTTCGGCTAACGCGGGCTG 3= flank forward ΔfepB
MP198 TCGATAGCGGCCGCCGCTGGCGCTTGTCGGCGTGC 3= flank reverse ΔfepB
MP199 TGACTAGATATCGCGCTCTGCTGGTGCTCCAGC 5= flank forward ΔentS
MP200 TGCATATCTAGAATTGTCAACGAAAGTTAAGTA 5= flank reverse ΔentS
MP201 TGCATATCTAGAGGATTGTCGGTTCATTACAGC 3= flank forward ΔentS
MP202 TCGATAGCGGCCGCCGGGTGAGCGTCTGCATCAGC 3= flank reverse ΔentS
MP207 TGACTAGATATCGCGCGGCAACCAGCGGTAAAC 5= flank forward Δfes
MP208 TGCATATCTAGAGGCCAACGCGAACCGATTATT 5= flank reverse Δfes
MP244 TGCATATCTAGATGCGCCTCATTAAGCGGGTCC 3= flank forward Δfes
MP231 TCGATAGCGGCCGCAATGACAGAATGTTAAGGACA 3= flank reverse Δfes
MP313 TGACTAGATATCCCTTAGCCGCCGCGCTTA 5= forward fepD::kan
MP314 TGCATATCTAGATTGCGGGTGAGCGTCTGC 3= reverse fepD::kan
ramKOA5=INsmaI TCCCCCGGGACCGCTTTGACGGTCAT 5= flank forward smr
ramKOA3=IN2 CGCGGTAGATTCCAAACATA 5= flank reverse smr
ramKOB5=IN ATCCTGACCAGACAAAAGCCCCATCC 3= flank forward smr
ramKOB3=INSma TCCCCCGGGGACAGCTGGCACATTTC 3= flank reverse smr
romA5=inXba GCTCTAGAGCCAGTCCGCTTCGGTAA 5= flank forward ΔromA
romA5=in CGACTTTCATCGCTTTCCTAATA 5= flank reverse ΔromA
romA3=in CGTCATATGCTCTCTCCTCTGAT 3= flank forward ΔromA
romA3=inXbaI GCTCTAGAGCACAGCTTAGCCAGGTG 3= flank reverse ΔromA
aRestriction sites are in bold.
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Extraction and quantification of capsule. Uronic acid was extracted and quantified as previously
described (28). Briefly, overnight cultures were grown in LB medium, subcultured to an OD600 of 0.2 in
fresh medium, and grown at 37°C. After 6 h, 500 l of culture was added to 100 l of 1% Zwittergent–
100 mM citric acid and incubated at 50°C for 20 min. Cells were pelleted, and 300 l of the supernatant
was added to 1.2 ml of absolute ethanol, incubated at 4°C for 20 min, and centrifuged for 5 min at maximum
speed. The pellet was resuspended in 200 l of dH2O, added to 1.2 ml of 12.5 mM sodium tetraborate in
sulfuric acid, and incubated for 5 min at 100°C. A 20-l volume of 0.15% 3-phenylphenol was added, and the
absorbance at 520 nm was measured. The glucuronic acid content was determined from a standard curve of
glucuronic acid (Sigma-Aldrich, St. Louis, MO) and expressed in micromoles per OD unit.
Measurement of promoter activity. Expression of the yersiniabactin-encoding locus was assessed
in vitro with a transcriptional gfp reporter containing the sequence 500 bp upstream of the ybtA
promoter cloned into pPROBE (33, 77). The bacteria were grown overnight at 37°C in LB medium,
subcultured to an OD600 of 0.2, and grown for 6 h with or without 200 M DP. All strains were assayed
in triplicate. Fluorescence was detected with a Synergy HT microplate reader (BioTek Instruments,
Winooski, VT) and measured in relative fluorescence units per OD600 unit.
In vitro growth curves. To monitor bacterial growth, bacterial strains were grown overnight in
M9-CAA at 37°C, subcultured to an OD600 of 0.05 in fresh medium in 250-ml flasks, and grown with
aeration for 6 h at 37°C. OD600 readings were recorded at the intervals indicated. Medium was
supplemented with 100 M DP to examine bacterial growth under iron-limiting conditions.
Cross-feeding assay. To determine if secreted siderophores could restore the growth of siderophore
mutants in iron-depleted medium, a cross-feeding assay was performed as previously described, with
minor modifications (78). Bacteria were grown overnight at 37°C in M9-CAA. Approximately 1  105 CFU
of each test strain was spread onto M9-CAA agar plates containing 100 M DP. Feeder strains were then
spotted (2.5 l of overnight culture) onto the agar, and the plates were incubated at 37°C overnight.
To determine if purified yersiniabactin could restore the growth of siderophore mutants in iron-
depleted medium, test strains were spread on M9-CAA agar as described above. Iron-free yersiniabactin
(EMC Microcollections, Germany) was resuspended in ethanol, and 10 l of either 1 mM or 100 M
yersiniabactin (diluted in dH2O) was spotted onto filter disks on the plate to assess yersiniabactin-
dependent growth complementation.
Statistical analysis. Statistical analyses were performed with GraphPad Prism, version 6.0 (GraphPad,
San Diego, CA).
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